NEW YORK (GenomeWeb News) - Accelrys and Agilent Technologies said yesterday that they have struck an agreement to resell each other's software to pharmaceutical companies through an integration and licensing agreement.
 
Under the agreement, Accelrys will resell Agilent's OpenLAB enterprise content manager, Kalabie electronic lab notebook, and GeneSpring gene expression software. Agilent will resell Accelrys' Accord cheminformatics solutions and Pipeline Pilot scientific operating platform.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.